Mobile App

Google Play Apple Store
Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused Strategies to Improve Outcomes
AMA/ABS/ANCC/ACPE - Virtual Symposium
In this live, interactive virtual symposium, expert faculty will inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. By using clinical case scenarios, this activity will clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Dr. Orlowski and Dr. Raje will lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).
View the live symposium to claim AMA/ABS/ANCC/ACPE credit after completion of the brief Post-Test/Evaluations.

Robert Orlowski, MD, PhD Robert Orlowski, MD, PhD
Professor of Medicine
Director, Section of Myeloma
The University of Texas, MD Anderson Cancer Center

Noopur Raje, MD Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital

20
Supported by an independent educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC




Mini Module
7733
VirtualSymposia_MM(1730x162).png
Hematology-Oncology

CookieConsent

Change Settings